drugset / Trial / NCT07064486
A Study of BGM0504 in Participants With Type 2 Diabetes in Indonesia
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial is conducted in Indonesia. The aim of the trial is to evaluate the efficacy and safety of BGM0504 versus semaglutide as add-on to metformin in patients with type 2 diabetes
Timeline
- Start
- 2025-07-04
- Primary completion
- 2026-07-31
- Completion
- 2026-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BGM0504 | Unknown | 5 mg | Subcutaneous |
| Subject | BGM0504 | Unknown | 10 mg | Subcutaneous |
| Comparator | Semaglutide | Peptide | 1 mg | Subcutaneous |